Regado Biosciences Inc., of Basking Ridge, N.J. was issued U.S. Patent No. 8,586,524, part of the “Modulators of Pharmacologic Agents” patent family, which identifies the classes of molecules that can be developed as control agents to modulate aptamer activity in the body.